InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,537.02
(
0.51%
)
US TECH 100
19,641.60
(
0.83%
)
Dow Jones
39,308.00
(
-0.06%
)
Brent Oil
87.08
(
-0.29%
)
Bitcoin
57,217.82
(
0.42%
)
Post# of 252484
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

poorgradstudent

Send PM Follow Ignore
Followers 73
Posts 3426
Boards Moderated 1
Alias Born 04/28/2004

poorgradstudent

Re: jq1234 post# 153645

Thursday, 12/06/2012 10:45:38 PM

Thursday, December 06, 2012 10:45:38 PM

Post# of 252484
PD-991:

These or maybe other concerns might explain why PFE conducted so few trials themselves on PD991.



Curious about that myself. There are clear references to this drug from 2004 SEC filings, yet the amount of clinical data out there seems limited. I admit to having missed the MM results you referred to.

Nonetheless, the results reported in BC looked good.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up